Enhancing the Medical Expenditure Panel Survey (MEPS) for Cancer Survivorship Research

这项协议的目的是让国家癌症研究所(NCI)为医疗支出小组调查(MEP)向医疗研究和质量机构(AHRQ)提供财政支持。该项目是NCI、疾病控制和预防中心(CDC)、国家卫生研究院行为和社会科学研究办公室(OBSSR)、卫生保健研究和质量机构(AHRQ)和美国癌症协会(ACS)共同努力的结果。OBSSR与NCI之间完成了直接引文。美国国立卫生研究院为ACS基金设立了一项捐赠基金。 医疗支出小组调查(MEPS)是由AHRQ对美国平民非制度化人口进行的具有全国代表性的调查。欧洲议会议员收集两年期间医疗保健和医疗保健支出的综合数据。 NCI、CDC、OBSSR和ACS之前与AHRQ合作创建了癌症补充剂MEPS体验，从前一年的全国健康访谈调查中对癌症幸存者的家庭进行了过度抽样，并对癌症幸存者的经济负担和获得护理的情况进行了一项特别调查。由于NHIS样本设计的变化，欧洲议会议员将无法在2024年的数据收集中对癌症幸存者进行过度抽样。目前的工作将从2024财年开始发布2024财年MEPS癌症体验调查的更新版。新版本的调查将包括与前一次调查相同的大部分问题，以便于比较趋势，并将用新的问题取代一些现在不那么关键或可从其他数据来源获得的调查项目，这些问题包括就业影响和工作场所住宿；生存护理；健康的社会决定因素；以及社会孤立和支持。

The purpose of this agreement is for the National Cancer Institute (NCI) to provide financial support to the Agency for Healthcare Research and Quality (AHRQ) for the Medical Expenditure Panel Survey (MEPS). This project is a collaborative effort between the NCI, the Centers for Disease Control and Prevention (CDC), the Office of Behavioral and Social Science Research (OBSSR) of the National Institutes of Health, the Agency for Healthcare Research and Quality (AHRQ), and the American Cancer Society (ACS). A direct citation was completed between OBSSR and NCI. An NIH gift fund was established for ACS funds. The Medical Expenditure Panel Survey (MEPS) is nationally representative survey of the civilian non-institutionalized population in the United States conducted by AHRQ. The MEPS collects comprehensive data on health care and health care expenditures over a two-year period. The NCI, CDC, OBSSR, and ACS collaborated previously with AHRQ to create the MEPS Experiences with Cancer Supplement, which oversampled households with cancer survivors from the prior year National Health Interview Survey and fielded a special survey about economic burden and access to care in cancer survivors. Due to a change in the NHIS sample design, MEPS will not be able to oversample cancer survivors in the 2024 data collection. The current effort will field an updated version of the MEPS Experiences with Cancer Survey in CY2024 starting in FY 2024. The new version of the survey will include most of the same questions as the earlier survey to allow comparisons of trends and will replace some survey items that are now less critical or available from other data sources with new questions on employment impacts and workplace accommodations; survivorship care; social determinants of health; and social isolation and support.